Contracts › 75D30126F00004
75D30126F00004: Metagenomic Next-Generation Sequencing (MNGS)
Awarded to Ginkgo Bioworks, Inc. by Centers for Disease Control and Prevention (CDC).
$3.2Mobligated
$3.2Mpotential value
14 April 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75D30126F00004 |
|---|---|
| Vehicle | 75D30124D20079 |
| Awardee | Ginkgo Bioworks, Inc. |
| Awarding agency | Centers for Disease Control and Prevention (CDC) |
| Awarding office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 621511 Medical Laboratories |
| PSC | Q301 Reference Laboratory Testing |
| Place of performance | MA |
| Offers received | 3 |
| Period of performance | 03 May 2026 to 14 April 2028 |
| Potential end | 14 April 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 621511 contracts · All expiring contracts · USASpending record